The acquisition of Cryoport’s specialty courier business is now finalized, with a value of approximately $200 million.

In the second part of her Pharma Commerce video interview, Kirsten Newquist, Identiv’s CEO, describes why this technology is essential for pharmaceutical safety and efficacy.

In the first part of her Pharma Commerce video interview, Kirsten Newquist, Identiv’s CEO, defines the term, and explains how ...

In the final part of her Pharma Commerce video interview, Maggie McCullough, PolicyMap’s CEO, illustrates how data-driven ...

A systematic review determines if adult patients with language barriers are less likely to use the video-based virtual care ...

In an interview with Pharmaceutical Executive, Barry Quart, CEO, Connect Biopharma, discussed his decision to join the company to advance rademikibart—a novel biologic therapy showing promise in ...

In order to succeed in today’s outcomes-driven healthcare landscape, pharmaceutical companies must move from traditional ...

The impact of Alzheimer’s disease is a prominent one, as it impacts an estimated 6.9 million US residents ages 65 and older. 1 This makes it the most common form of dementia, while other forms include ...

In the second part of her Pharma Commerce video interview, Maggie McCullough, PolicyMap’s CEO, details what the company’s ...

Marketed as BNT327, the PD-L1xVEGF-A bispecific antibody has the potential to become what the involved parties believe is a ...

In the final part of his Pharma Commerce video interview, Scott Tillman, Logility’s senior vice president of innovation, ...